SE9503476D0 - New combination - Google Patents

New combination

Info

Publication number
SE9503476D0
SE9503476D0 SE9503476A SE9503476A SE9503476D0 SE 9503476 D0 SE9503476 D0 SE 9503476D0 SE 9503476 A SE9503476 A SE 9503476A SE 9503476 A SE9503476 A SE 9503476A SE 9503476 D0 SE9503476 D0 SE 9503476D0
Authority
SE
Sweden
Prior art keywords
pct
pharmaceutically acceptable
sec
new combination
acceptable salt
Prior art date
Application number
SE9503476A
Other languages
English (en)
Swedish (sv)
Inventor
Arne Eek
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9503476A priority Critical patent/SE9503476D0/xx
Publication of SE9503476D0 publication Critical patent/SE9503476D0/xx
Priority to DE69631597T priority patent/DE69631597T2/de
Priority to US08/765,133 priority patent/US5908847A/en
Priority to ES96933709T priority patent/ES2214548T3/es
Priority to DK96933709T priority patent/DK0862462T3/da
Priority to AT96933709T priority patent/ATE259657T1/de
Priority to PCT/SE1996/001248 priority patent/WO1997012634A1/fr
Priority to PT96933709T priority patent/PT862462E/pt
Priority to EP96933709A priority patent/EP0862462B1/fr
Priority to CA002233677A priority patent/CA2233677C/fr
Priority to NZ319746A priority patent/NZ319746A/xx
Priority to JP51420397A priority patent/JP4135977B2/ja
Priority to AU72335/96A priority patent/AU706794B2/en
Priority to NO19981222A priority patent/NO318387B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Medicines Containing Plant Substances (AREA)
SE9503476A 1995-10-06 1995-10-06 New combination SE9503476D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9503476A SE9503476D0 (sv) 1995-10-06 1995-10-06 New combination
AU72335/96A AU706794B2 (en) 1995-10-06 1996-10-03 A novel combination of a beta-receptor blocker and an opioid
PCT/SE1996/001248 WO1997012634A1 (fr) 1995-10-06 1996-10-03 NOUVELLE COMBINAISON D'UN AGENT DE BLOCAGE DE β-RECEPTEUR ET D'UN OPIACE
US08/765,133 US5908847A (en) 1995-10-06 1996-10-03 Combination of a β-receptor blocker and an opioid
ES96933709T ES2214548T3 (es) 1995-10-06 1996-10-03 Combinacion de un bloqueante de los beta-receptores y un opioide.
DK96933709T DK0862462T3 (da) 1995-10-06 1996-10-03 Kombination af en beta-receptorblokker og et opioid
AT96933709T ATE259657T1 (de) 1995-10-06 1996-10-03 Kombination aus einem beta rezeptorblocker und einem opioid
DE69631597T DE69631597T2 (de) 1995-10-06 1996-10-03 Kombination aus einem beta rezeptorblocker und einem opioid
PT96933709T PT862462E (pt) 1995-10-06 1996-10-03 Uma nova combinacao de um bloqueador de receptores beta e de um opioide
EP96933709A EP0862462B1 (fr) 1995-10-06 1996-10-03 Combinaison d'un agent de blocage de beta-recepteur et d'un opiace
CA002233677A CA2233677C (fr) 1995-10-06 1996-10-03 Nouvelle combinaison d'un agent de blocage de .beta.-recepteur et d'un opiace
NZ319746A NZ319746A (en) 1995-10-06 1996-10-03 A synergisitic combination of a beta-receptor blocker and an opioid
JP51420397A JP4135977B2 (ja) 1995-10-06 1996-10-03 β−受容体遮断薬とオピオイドとの新規な組合せ物
NO19981222A NO318387B1 (no) 1995-10-06 1998-03-18 Anvendelse av en kombinasjon av en beta-reseptorblokker og et opioid ved behandling av smerte.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9503476A SE9503476D0 (sv) 1995-10-06 1995-10-06 New combination

Publications (1)

Publication Number Publication Date
SE9503476D0 true SE9503476D0 (sv) 1995-10-06

Family

ID=20399727

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9503476A SE9503476D0 (sv) 1995-10-06 1995-10-06 New combination

Country Status (14)

Country Link
US (1) US5908847A (fr)
EP (1) EP0862462B1 (fr)
JP (1) JP4135977B2 (fr)
AT (1) ATE259657T1 (fr)
AU (1) AU706794B2 (fr)
CA (1) CA2233677C (fr)
DE (1) DE69631597T2 (fr)
DK (1) DK0862462T3 (fr)
ES (1) ES2214548T3 (fr)
NO (1) NO318387B1 (fr)
NZ (1) NZ319746A (fr)
PT (1) PT862462E (fr)
SE (1) SE9503476D0 (fr)
WO (1) WO1997012634A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100306707B1 (ko) * 1998-09-07 2003-01-24 한국전기통신공사 교차이득변조형반도체광파장변환기
US7041365B2 (en) * 2003-05-12 2006-05-09 3M Innovative Properties Company Static dissipative optical construction
WO2011126910A2 (fr) * 2010-03-30 2011-10-13 Algynomics Inc. Compositions et procédés pour le traitement de troubles somatosensoriels
US8716350B2 (en) 2010-03-30 2014-05-06 Algynomics Inc. Compositions and methods for the treatment of somatosensory disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4885173A (en) * 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities

Also Published As

Publication number Publication date
ES2214548T3 (es) 2004-09-16
CA2233677C (fr) 2006-08-29
JP4135977B2 (ja) 2008-08-20
NZ319746A (en) 1999-11-29
EP0862462A1 (fr) 1998-09-09
DK0862462T3 (da) 2004-05-10
EP0862462B1 (fr) 2004-02-18
NO318387B1 (no) 2005-03-14
DE69631597T2 (de) 2004-12-16
CA2233677A1 (fr) 1997-04-10
NO981222D0 (no) 1998-03-18
AU706794B2 (en) 1999-06-24
NO981222L (no) 1998-03-18
AU7233596A (en) 1997-04-28
JPH11513386A (ja) 1999-11-16
WO1997012634A1 (fr) 1997-04-10
ATE259657T1 (de) 2004-03-15
DE69631597D1 (de) 2004-03-25
US5908847A (en) 1999-06-01
PT862462E (pt) 2004-06-30

Similar Documents

Publication Publication Date Title
PL312219A1 (en) Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids
DE69805973T2 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
EP1311242A4 (fr) Systemes de liberations d'agents actifs et procedes de protection et d'administration d'agents actifs
AU2003268144A1 (en) Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist
HU9203779D0 (en) (+)-alpha-(2,3-dimethoxi-phenyl)-1-[2-(4-fluoric-phenyl)-ethyl]-4-piperidine-methanole
AU3611299A (en) Use of metalloprotinease inhibitors for inducing and/or stimulating growth of hair or hairs and/or for slowing down their loss
WO1998026770A3 (fr) Utilisation locale d'agonistes opioïdes kappa dans le traitement de la douleur oculaire
DE69934689D1 (de) Verwendung der protein-kinase-c-epsilon-inhibitoren zur behandlung von schmerzen
SE9503476D0 (sv) New combination
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
PL312198A1 (en) Application of procaine in obtaining a pharmaceutical preparation of analgesic activity with minimum motorial blocking effect
GB9802542D0 (en) New use
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
HK1046847A1 (en) Pharmaceutical combination with analgesic action containing paracetamol and buspirone.
HK1005651A1 (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
BR9708037A (pt) Método para o tratamento de abuso de substância
CA2341891A1 (fr) Utilisation de r(+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol pour le traitement de troubles du sommeil
DE69428276T2 (de) Insulinähnlicher wachstumfaktor ii als antitumormittel
BG100479U (en) Medicament for the local treatment of otitis